Context: Heritability of diabetes is associated with hyperinsulinemia, impaired endothelial function, and inflammatory up-regulation. However, no studies have examined whether a family history of diabetes (FHD) effects placental vascular circulation.
A family history of diabetes (FHD) is an independent and significant predictor of type 2 diabetes incidence (1-3). However, even in the absence of diabetes, insulin resistance as well as b-cell dysfunction have been identified in individuals with a first-degree FHD (4). Moreover, first-degree relatives of patients with type 2 diabetes mellitus are suggested to have an increased risk of becoming overweight and obese in middle age, as well as an increased susceptibility to cardiovascular disease (5, 6) . It has been shown that endothelium-dependent vasodilation decreases by 38%, whereas carotid intima media thickness increases by 18% in first-degree relatives of patients with diabetes (7) . Experimental and clinical studies have demonstrated that heritability of diabetes is associated with marked hyperinsulinemia, impaired endothelial function, and inflammatory up-regulation in different patient populations (8, 9) . However, data regarding pregnancy outcome in first-degree relatives of patients with diabetes, are limited. Moreover, no studies have examined whether a FHD effects placental maternal and fetal vascular circulation, or placental inflammatory response. The current study was designed to investigate the impact of a first-degree FHD on placental vascular circulation and inflammatory lesions, as well as pregnancy outcome.
Materials and Methods

Subjects
The study group consisted of 339 pregnant women who gave birth and underwent a placental histopathological examination at the Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Israel between 2007 and 2013. Exclusion criteria included multiple pregnancy, fetus with known anomaly or abnormal karyotype, preterm labor (defined as delivery before 37 weeks of gestation), and clinical chorioamnionitis. In this cohort study, sequential pregnancies were not included. Obesity was defined using World Health Organization criteria [body mass index (BMI) $ 30 kg/m 2 ]. Metabolic risk factors included pregestation hypertension, diabetes mellitus, hyperlipidemia, and current cigarette smoking. The following data were collected from the medical files: maternal characteristics (i.e., age, gravidity, parity, prepregnancy and delivery BMI, FHD, and hypertension), pregestational metabolic risk factors (i.e., diabetes mellitus, hypertension, current smoking, and hyperlipidemia), fasting plasma glucose levels, pregnancy complications [i.e., gestational diabetes mellitus (GDM), gestational hypertensive disorder (GHD; i.e., gestational hypertension and preeclampsia)], and neonatal outcome parameters (i.e., week of delivery, birth weight, macrosomia, hypoglycemia and jaundice). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the local institutional review board.
Early pregnancy screening for undiagnosed hyperglycemia was performed using the patient's medical history, clinical risk factors, and fasting glucose levels. If the result of early testing was negative, a repeat screening at 24 to 28 weeks of gestation was conducted. We used the two-step approach, which is based on a first screening with the administration of 50 g of an oral glucose solution, followed by a 1-hour venous glucose determination. Those individuals meeting or exceeding the screening threshold underwent a 100-g, 3-hour diagnostic oral glucose tolerance test, using the Carpenter-Coustan criteria for GDM.
The study was approved by the local Institutional Review Board.
Placental examination
We analyzed placental histology according to the criteria of the Society for Pediatric Pathology (10) with the 2016 Amsterdam Placental Workshop Group Consensus Statement modifications (11) , subdividing placental findings to lesions consistent with maternal vascular and fetal vascular malperfusion, as well as inflammatory response of maternal and fetal origin. A standard protocol was used for placental pathology examinations (12) .
Placental lesions
Maternal vascular supply (MVS) abnormalities included vascular lesions related to maternal mal-perfusion (i.e., acute atherosis and mural hypertrophy) and villous changes related to maternal mal-perfusion (i.e., increased syncytial knots, villous agglutination, increased intervillous fibrin deposition, distal villous hypoplasia, and villous infarcts). A representative image of MVS abnormalities is shown in Fig. 1 .
Fetal vascular supply (FVS) abnormalities included vascular lesions related to fetal mal-perfusion and thrombo-occlusive disease (i.e., vascular and villous changes consistent with fetal thrombo-occlusive disease). A representative image of MVS abnormalities is shown in Fig. 1 All placental pathological examinations were performed by a single pathologist who was unaware of maternal family history and metabolic parameters.
Statistical analysis SPSS 9.0 statistical analysis software (SPSS Inc., Chicago, IL) was used for data analysis. Descriptive statistics were calculated and reported as mean 6 standard deviation for continuous variables (e.g., hemodynamic and biochemistry parameters). Distributions of continuous variables were assessed for normality using the Kolmogorov-Smirnov test (cutoff at P = 0.01). Categorical variables (e.g., sex, comorbidities, and treatment prescriptions) were described using frequency distributions, and are presented as frequency (%). Multivariate general linear modeling was arrived at using a backward stepwise approach, with probability of F = 0.05 for entry and 0.15 for removal from the model. All tests were two-sided and considered significant at P , 0.05.
Results
Three hundred thirty-nine pregnant women (mean age 32 6 4 years) were divided into two groups according to the presence of a first-degree FHD. Group 1 included 225 subjects without FHD, and group 2 included 114 subjects with FHD. Demographic and clinical characteristics of the two groups are presented in Table 1 . As can be seen, the study groups were similar in terms of age (P = 0.123), gravidity (P = 0.103), and parity (P = 0.720). Whereas pregestational BMI was significantly higher in subjects with a first-degree FHD (P = 0.001), weight gain during the pregnancy did not differ significantly between groups (P = 0.253). Week at delivery was slightly but significantly earlier in women with FHD (P = 0.045).
Placental findings
Placental findings of the study groups are presented in Table 2 . As can be seen, MVS abnormalities of the placental bed differed significantly across groups, and were higher in subjects with FHD compared with those without FHD (54% vs 34%, P , 0.0001). Vascular lesions related to maternal mal-perfusion, as well as villous changes related to maternal mal-perfusion, were significantly higher in group 2 than group 1 (17% vs 6%, P = 0.001 and 41% vs 28%, P = 0.011, respectively). FVS abnormalities rate, as well as fetal and maternal inflammatory response, did not differ significantly between groups. Multiple linear regression analysis (Table 3 ) was arrived at using a backward, stepwise approach, with probability of F = 0.05 for entry and 0.15 for removal from the model. Backward elimination was performed to identify variables independently associated with MVS. In this model, a first-degree FHD emerged as a significant predictor of MVS abnormalities, independent of age, pregestational BMI, and more than doubled the risk of this outcome [odds ratio (OR) 2.084, 95% confidence interval (CI), 1.337 to 3.247, P = 0.001]. The model was significant (P , 0.0001), and correctly classified 66.9% of the study participants for this outcome.
Pregnancy outcome
Pregnancy outcome data are presented in Table 1 . GDM incidence was significantly higher in subjects with GHDs incidence, including preeclampsia and gestational hypertension, was significantly higher in individuals with a first-degree FHD, compared with subjects without FHD (16% vs 6%, P = 0.003). Multiple linear regression analysis (Table 3) was arrived at using a backward, stepwise approach to identify variables independently associated with GHD. In this model, age (OR 1.92, 95% CI, 0.85 to 0.99, P = 0.031), prepregnancy BMI (OR 1.11, 95% CI, 1.06 to 1.16, P , 0.0001), and marginally weight gain during pregnancy (OR 1.045, 95% CI, 0.99 to 1.1, P = 0.091), remained significant predictors of GHD. Although a FHD did not significantly predict this outcome, removing it lessened the value of the model. The model was significant (P , 0.0001) and correctly classified 79.9% of study participants.
Among neonatal outcome parameters, fetal hypoglycemia incidence was significantly higher in the FHD group compared with subjects without FHD (17% vs 7%, P = 0.008). Multivariable logistic regression analysis with a backward, stepwise approach was carried out to identify variables independently associated with neonatal hypoglycemia. The model was significant (P , 0.0001) and correctly classified 89.4% of subjects for this end point. Pregestational diabetes increased the risk of hypoglycemia (OR 4.859, 95% CI, 1.69 to 13.973, P = 0.003), as did macrosomia (OR 2.498, 95% CI, 1.222 to 5.107, P = 0.012). GDM was marginally associated with hypoglycemia (OR 2.113, 95% CI, 0.911 to 4.901, P = 0.081). Family diabetes mellitus was not significantly associated with this outcome (OR 1.483, 95% CI, 0.712 to 3.089, P = 0.292). 
Discussion
The major finding was that a first-degree FHD significantly increased MVS abnormalities of the placental bed, including vascular as well as villous lesions consistent with maternal mal-perfusion. A first-degree FHD emerged as a significant predictor of MVS abnormalities, independent of age and pregestational BMI, and more than doubled the risk of this outcome. Additionally, we found that GDM incidence was significantly higher in subjects with FHD. Moreover, a first-degree FHD and pregestational BMI remained significant and independent predictors of GDM, even after multivariable adjustment. The pathophysiology that links the heritability of diabetes to vascular circulation abnormalities is not fully understood. Individuals with a first-degree FHD share the same genetic background as diabetic patients, and experience multiple metabolic alterations years before the onset of hyperglycemia (4) . A prospective cohort study of nondiabetic individuals with a first-degree FHD demonstrated that individuals with deteriorating glucose tolerance, whom are genetically predisposed for diabetes, exhibited insulin resistance and b-cell dysfunction (13) . Individuals with a first-degree FHD inherit the susceptibility for impaired insulin activity, represented by decreased protein expression of insulin receptor substrate 2 and mRNA expression of tissue inhibitor metalloproteinase (14) . Recently published data found a significant increase in serum adipocyte fatty acid binding protein levels in normoglycemic individuals with a firstdegree FHD, supporting the assumption that adipocyte dysfunction appears before the occurrence of glucose metabolism abnormalities, and contributes to the development of insulin resistance in individuals with a firstdegree FHD (15) . Reduced insulin action in peripheral tissue impairs endothelium-dependent vasodilatation, and bioavailability of nitric oxide, as well as increasing the local activity of growth factors in vascular tissue (8, 16, 17) . Clinical studies have revealed that endotheliumdependent vasodilation decreases by 38% in first-degree relatives of patients with diabetes (7). A reciprocal relationship between insulin resistance and endothelial dysfunction is considered to be a key initiating step in the atherosclerotic cascade. Abnormalities of endothelial function may contribute to atherosclerosis before overt diabetes develops (8) . Thus, a FHD is proposed to be a significant risk factor of atherosclerosis, and is closely related to the occurrence of future cardiovascular disease (18) .
In the current study, we demonstrated that an FHD is associated with placental vascular supply abnormalities, including vascular as well as villous lesions related to maternal mal-perfusion, and after multivariable adjustment more than doubled the risk of this outcome. Therefore, the findings of the current study further support the notion that genetic factors might link family history, gestational disease, and future cardiovascular disease in women (19, 20) .
Consistent with previously published data, the current study demonstrated that GDM incidence is significantly higher in subjects with a first-degree FHD (21, 22) . Importantly, in the current study, not only did a first-degree FHD significantly increase diabetes incidence, but FHD was associated with advanced glucose dysregulation, which required insulin treatment during pregnancy. A first-degree history of diabetes remained a significant independent predictor of GDM incidence, and more than doubled the risk of this outcome even after multivariable adjustment. Additionally, consistent with previously published data, the current study demonstrated that pregestational BMI significantly increased risk of GDM incidence (23) .
In the current study, the incidence of GHDs, comprising preeclampsia and gestational hypertension, was significantly higher in individuals with a first-degree FHD. However, after multivariable adjustment, a FHD did not significantly predict this outcome. The independent predictors of GHD included age, pregestational BMI, and marginally weight gain during pregnancy.
Among neonatal outcome parameters, fetal hypoglycemia incidence was significantly higher in the FHD group compared with subjects without FHD. However, in multivariable logistic regression analysis family diabetes mellitus was not significantly associated with this outcome. The independent predictors of neonatal hypoglycemia included pregestational diabetes and fetal macrosomia. GDM was marginally associated with neonatal hypoglycemia.
There are some limitations to the current study. First, the cross-sectional study design precluded the ability to determine a causal relationship between the placental vascular abnormalities and genetic factors, such as family history. Second, as this was a retrospective study, we did not have access to data that could have contributed to the study findings, including fasting insulin and homeostasis model assessment of insulin resistance measurements to investigate impact of these parameters on pregnancy and neonatal outcome, and paternal FHD to investigate the impact of the double genetic burden of FDH (e.g., on the maternal and paternal side) on placental vascular circulation. Third, since in this cohort study data from sequential pregnancies were not collected, information regarding GDM in past pregnancies would have added another interesting dimension to the current study, as well as indicating if there was a cumulative effect of GDM in sequential pregnancies on the outcome measure. Thus, future longitudinal studies are needed to confirm these findings.
In conclusion, we demonstrated that a first-degree FHD is associated with an increased rate of maternal vascular mal-perfusion abnormalities as well as an adverse pregnancy outcome. Thus, comprehensive family histories should be obtained for all pregnant women, and maximal effort should be invested in carefully evaluating and monitoring each woman with a FHD.
